Wild-type human disease-associated ORFs were selected from the human ORFeome version 8.1 [27 (link)]. As described in Sun et al [17 (link)], human ORFs with disease-associated variants were constructed by site-directed mutagenesis using the Thermo Scientific Phusion Site-Directed Mutagenesis Kit. The Gateway Donor plasmid was amplified using phosphorylated primers that introduce the desired changes followed by a 5-minute, room-temperature ligation reaction. The resulting plasmid was then transformed into NEB5α competent E. coli cells (New England Biolabs).
Free full text: Click here